Astria Therapeutics Inc (ATXS)
9.55
+0.12
(+1.27%)
USD |
NASDAQ |
May 17, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Astria Therapeutics Total Liabilities (Quarterly): 11.07M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.07M |
| December 31, 2023 | 11.55M |
| September 30, 2023 | 9.382M |
| June 30, 2023 | 6.651M |
| March 31, 2023 | 6.88M |
| December 31, 2022 | 9.417M |
| September 30, 2022 | 6.945M |
| June 30, 2022 | 5.874M |
| March 31, 2022 | 4.967M |
| December 31, 2021 | 5.203M |
| September 30, 2021 | 4.70M |
| June 30, 2021 | 4.046M |
| March 31, 2021 | 249.88M |
| December 31, 2020 | 6.787M |
| September 30, 2020 | 7.539M |
| June 30, 2020 | 6.227M |
| March 31, 2020 | 5.465M |
| December 31, 2019 | 6.06M |
| September 30, 2019 | 5.561M |
| Date | Value |
|---|---|
| June 30, 2019 | 5.168M |
| March 31, 2019 | 4.628M |
| December 31, 2018 | 4.227M |
| September 30, 2018 | 4.18M |
| June 30, 2018 | 5.035M |
| March 31, 2018 | 5.359M |
| December 31, 2017 | 6.105M |
| September 30, 2017 | 7.656M |
| June 30, 2017 | 9.266M |
| March 31, 2017 | 9.467M |
| December 31, 2016 | 11.12M |
| September 30, 2016 | 12.08M |
| June 30, 2016 | 11.75M |
| March 31, 2016 | 12.54M |
| December 31, 2015 | 13.68M |
| September 30, 2015 | 14.11M |
| June 30, 2015 | 14.87M |
| March 31, 2015 | 13.24M |
| December 31, 2014 | 89.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.046M
Minimum
Jun 2021
249.88M
Maximum
Mar 2021
18.97M
Average
6.439M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 378.81M |
| Shareholders Equity (Quarterly) | 367.74M |